Writing Group Disclosures

Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers’ Bureau/ HonorariaExpert WitnessOwnership InterestConsultant/Advisory BoardOther
Kiran MusunuruUniversity of Pennsylvania Cardiovascular InstituteNoneNoneNoneNoneNoneNoneNone
Farah SheikhUniversity of California-San DiegoNoneNoneNoneNoneNoneNoneNone
Rajat M. GuptaHarvard UniversityNoneNoneNoneNoneNoneNoneNone
Steven R. HouserTemple University School of Medicine Cardiovascular Research CenterNoneNoneNoneNoneNoneNoneNone
Kevin O. MaherEmory University, Children’s Healthcare of AtlantaNoneNoneNoneNoneNoneNoneNone
David J. MilanMassachusetts General HospitalNoneNoneNoneNoneNoneNoneNone
Andre TerzicMayo Clinic Center for Regenerative MedicineNoneNoneNoneNoneNoneNoneNone
Joseph C. WuStanford University School of Medicine, Stanford Cardiovascular InstituteNIH*NoneNoneNoneNoneNoneNone
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Significant.